Hypera S.A.

B3:HYPE3.SA

25.94 (BRL) • At close October 17, 2024
Bedrijfsnaam Hypera S.A.
Symbool HYPE3.SA
Munteenheid BRL
Prijs 25.94
Beurswaarde 16,400,764,634
Dividendpercentage 3.99%
52-weken bereik 25.87 - 37.18
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Breno Toledo Pires de Oliveira
Website https://www.hyperapharma.com.br

An error occurred while fetching data.

Over Hypera S.A.

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex

Vergelijkbare Aandelen

Sartorius Stedim Biotech S.A. logo

Sartorius Stedim Biotech S.A.

DIM.PA

208 EUR

Raia Drogasil S.A. logo

Raia Drogasil S.A.

RADL3.SA

25.34 BRL

Eurofins Scientific SE logo

Eurofins Scientific SE

ERF.PA

56.22 EUR

argenx SE logo

argenx SE

ARGX.BR

441.9 EUR

UCB SA logo

UCB SA

UCB.BR

176.7 EUR

Grifols, S.A. logo

Grifols, S.A.

GRF.MC

9.846 EUR

Fisher & Paykel Healthcare Corporation Limited logo

Fisher & Paykel Healthcare Corporation Limited

FPH.NZ

20.7 NZD

bioMérieux S.A. logo

bioMérieux S.A.

BIM.PA

106.6 EUR

Ipsen S.A. logo

Ipsen S.A.

IPN.PA

116.8 EUR

Financiële Gegevens

Cijfers zijn in miljoenen (BRL)

Cijfers zijn in miljoenen (BRL)